SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    E Giagkou, DK Christodoulou, KH Katsanos, Mouth cancer in inflammatory bowel diseases, Oral Diseases, 2016, 22, 4
  2. You have free access to this content2
    N. E. Gilhus, A. Nacu, J. B. Andersen, J. F. Owe, Myasthenia gravis and risks for comorbidity, European Journal of Neurology, 2015, 22, 1
  3. 3
    Nils Erik Gilhus, Jan J Verschuuren, Myasthenia gravis: subgroup classification and therapeutic strategies, The Lancet Neurology, 2015, 14, 10, 1023

    CrossRef

  4. 4
    Iain J. McGurgan, Christopher McGuigan, Nonmelanoma skin cancer risk awareness in azathioprine-treated myasthenia gravis patients, Brain and Behavior, 2015, 5, 10
  5. 5
    Konstantinos H. Katsanos, Giulia Roda, Alexandre Brygo, Emmanuel Delaporte, Jean-Frédéric Colombel, Oral Cancer and Oral Precancerous Lesions in Inflammatory Bowel Diseases: A Systematic Review, Journal of Crohn's and Colitis, 2015, 9, 11, 1043

    CrossRef

  6. 6
    E. G. Pedersen, A. Pottegård, J. Hallas, S. Friis, K. Hansen, P. E. H. Jensen, D. Gaist, Myasthenia and risk of cancer: a population-based case–control study, European Journal of Neurology, 2014, 21, 5
  7. 7
    Sui H. Wong, Saif Huda, Angela Vincent, Gordon T. Plant, Ocular Myasthenia Gravis: Controversies and Updates, Current Neurology and Neuroscience Reports, 2014, 14, 1

    CrossRef

  8. 8
    A. H. V. Schapira, Recent advances in neurology 2013–2014, European Journal of Neurology, 2014, 21, 12
  9. 9
    E. G. Pedersen, A. Pottegård, J. Hallas, S. Friis, K. Hansen, P. E. H. Jensen, D. Gaist, Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprine , European Journal of Neurology, 2014, 21, 3
  10. 10
    Kyung-Ah Park, Sei Yeul Oh, Current treatment for ocular myasthenia gravis, Expert Review of Ophthalmology, 2013, 8, 6, 595

    CrossRef